Lab bankruptcies thwart Medicare efforts to recover millions in testing overcharges – STAT
F ive years ago, Companion DX Reference Lab hoped to cash in on cutting-edge genetic tests paid for by Medicare. The Houston lab marketed a test to assess how a persons genes affect tolerance for drugs such as opiates used to treat chronic pain. It also ran DNA tests to help treat cancer and urine…